Hospitalisation Resulting from Medicine-Related Problems in Adult Patients with Cardiovascular Diseases and Diabetes in the United Kingdom and Saudi ArabiaReportar como inadecuado




Hospitalisation Resulting from Medicine-Related Problems in Adult Patients with Cardiovascular Diseases and Diabetes in the United Kingdom and Saudi Arabia - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

1

Department of Pharmacy, Pharmacology and Postgraduate Medicine, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK

2

Medication Safety Research Chair, College of Pharmacy, King Saud University, Riyadh P.O. Box 2457, Saudi Arabia





*

Author to whom correspondence should be addressed.



Academic Editor: Omorogieva Ojo

Abstract Cardiovascular diseases CVDs and diabetes DM are two interrelated conditions that have a heavy morbidity and mortality burden worldwide. Patients with the two conditions usually take multiple medicines and thus are more susceptible to medicine-related problems MRPs. MRPs can occur at any stage of the treatment process and in many cases can lead to unplanned hospitalisations. The aim of the study was to determine the prevalence of hospitalisation resulting from MRPs in adult patients with CVDs and-or DM and to identify the main causes, risk factors, and medicine classes involved. A retrospective study included 300 adult patients from two hospitals, one in the United Kingdom and one in Saudi Arabia. To identify MRPs, medical records were reviewed for demographic data, clinical data, laboratory assay, and prescription records. A total of 197 65.7% patients had MRPs, of which less than 10% were severe. The main problems were lack of treatment effectiveness and adverse drug reactions. Moreover, polypharmacy and patient non-adherence were the main risk factors contributing to MRPs. The main medicine classes associated with MRPs were insulin and antihypertensive medicines. Further research should address the pharmaceutical care processes employed in treating CVDs and DM, and to empower patients-healthcare providers in tackling MRPs. View Full-Text

Keywords: cardiovascular diseases; diabetes; prevalence; medicine-related problems; hospitalisation; treatment effectiveness; adverse drug reactions; polypharmacy cardiovascular diseases; diabetes; prevalence; medicine-related problems; hospitalisation; treatment effectiveness; adverse drug reactions; polypharmacy





Autor: Abdullah Al Hamid 1,* , Zoe Aslanpour 1, Hisham Aljadhey 2 and Maisoon Ghaleb 1

Fuente: http://mdpi.com/



DESCARGAR PDF




Documentos relacionados